CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
SinuSonic Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04404036
NCT04404036N/ACompleted
CompareCT.gov

Treatment of Eustachian Tube Dysfunction (ETD) and Facial Pain With Combined Acoustic Vibration and Oscillating Expiratory Pressure

Medical University of South Carolina·interventional·Posted May 27, 2020·Updated Feb 13, 2026

In Brief

A clinical study evaluating SinuSonic Device for Eustachian Tube Dysfunction and Facial Pain. Completed, enrolled 30 participants across 1 site.

Detailed Summary

This study was originally designed with three aims: (1) healthy controls to assess nasal nitric oxide, (2) adults with Eustachian Tube Dysfunction (ETD), and (3) adults with facial pain/pressure. However, only the ETD cohort (Aim 2) was initiated and enrolled. During study conduct, additional symptom and pain assessments (including MPQ-SF and mBPI-sf) were collected in the ETD cohort for exploratory purposes. All results in this record reflect ETD cohort participants who used the SinuSonic device twice daily for 6 weeks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEustachian Tube Dysfunction, Facial Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 27, 2020
Enrollment StartApr 28, 2020
Primary CompletionApr 25, 2023
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.1 years ago

Interventions

SinuSonic Devicedevice

A medical device that combines acoustic vibration with oscillating expiratory pressure.